AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

CRISPR Therapeutics AG (CRSP)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

40.27

1.91 (4.98%)

At close: Jan 15, 2025, 11:04 AM

CRISPR Therapeutics AG Forecast

Stock Price Forecast

The 18 analysts with 12-month price forecasts for CRSP stock have an median target of 84, with a low estimate of 48 and a high estimate of 105. The median target predicts an increase of 108.59% from the current stock price of 40.27.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$48	$77.6	$84	$105
Change	19.20%	92.70%	108.59%	160.74%

AI Analyst Report

New

Needham has maintained a Buy rating for CRISPR The... Unlock content with Pro Subscription

Updated Jan 14, 2025

Rating	Jun 24	Aug 24	Oct 24	Nov 24	Dec 24	Jan 25
Strong Buy	0	0	0	0	0	0
Buy	3	3	0	1	2	2
Hold	1	4	1	2	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	7	1	3	2	2

Financial Forecast this Year

Revenue This Year

11.08M

from 371.21M

-97%

from 371.21M

Revenue Next Year

124.40M

from 11.08M

1.02K%

from 11.08M

EPS This Year

-5.18

from -1.94

-167%

from -1.94

EPS Next Year

-4.99

from -5.18

3.7%

from -5.18